“The evidence is quite clear that the medications that are currently FDA-approved and prescribed to treat ADHD in particular are fairly well tolerated.
Donna Werling, PhD – Slide of the Week
Title: Use of the new human telomere-to-telomere genomic reference improves variant calling and phasing in regions flanking developmental disorder-associated copy number variants Legend: Genotyping and switch error rates spike in areas flanking CNV disorder associated regions. …
Health trajectory of mothers of children with developmental disabilities shows a ‘wear-and-tear’ effect starting around age 65
Mothers of children with developmental disabilities experience long-term stress, adapting for many years but showing signs of ‘wear-and-tear’ starting around age 65, affecting their physical and mental health.
Guanfacine for Hyperactivity in Children with Down Syndrome (Stanley)
Is your child with down syndrome hyperactive, inattentive, or impulsive?
If so, you may be interested in this new research study
Marsha R. Mailick, PhD – Slide of the Week
Parenting a child with a developmental disability can be a profound source of stress, particularly for mothers.
Spring showers bring May flowers… and food! Waisman dietitians host classes on low-protein cooking and gardening for individuals with PKU.
The team of dietitians from the Waisman Center’s Biochemical Genetics Clinic hosted a morning event with a cooking and container gardening class for individuals with PKU and their families.
Genetic blueprint behind early brain development uncovered by team of Waisman investigators
Early neuronal maturation is not well understood. A new study at Waisman was able to map the gene and regulatory networks driving early neuronal maturation for the first time.
Daifeng Wang, PhD – Slide of the Week
Cellular processes like development, differentiation, and disease progression are highly complex and dynamic (e.g., gene expression).
Kay Emerson and Harry Waisman, two pioneers in PKU
Kay Emerson was the first person in Wisconsin and one of the first in the United States to be successfully treated for phenylketonuria (PKU), a condition in which the body fails to break down the amino acid phenylalanine, causing a buildup.
New research reveals parallels between Alexander disease and other neurodegenerative conditions like Alzheimer’s disease
New research from Waisman investigator, Tracy Hagemann, PhD, associate research professor, delves into the cognitive impairments and associated molecular changes caused by Alexander disease (AxD), revealing similarities to other neurodegenerative diseases like Alzheimer’s.